Axogen, Inc. Share-based Payment Arrangement, Expense
Axogen, Inc. (AXGN) reported Share-based Payment Arrangement, Expense of $5.42 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-10-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2025-10-29
- Axogen, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $5.42M, a 8.39% increase year-over-year.
- Axogen, Inc. share-based payment arrangement, expense for the quarter ending 2025-06-30 was $5.17M, a 32.28% increase year-over-year.
- Axogen, Inc. share-based payment arrangement, expense for the quarter ending 2025-03-31 was $2.91M, a 25.77% decline year-over-year.
- Axogen, Inc. share-based payment arrangement, expense for the quarter ending 2024-09-30 was $5.00M, a 5.41% increase year-over-year.
- Axogen, Inc. share-based payment arrangement, expense for fiscal 2021 was $10.92M, a 28.91% increase from fiscal 2020.
- Axogen, Inc. share-based payment arrangement, expense for fiscal 2020 was $8.47M, a 17.80% decline from fiscal 2019.
- Axogen, Inc. share-based payment arrangement, expense for fiscal 2019 was $10.30M, a 35.47% increase from fiscal 2018.
- Axogen, Inc. share-based payment arrangement, expense for fiscal 2018 was $7.61M, a 110.75% increase from fiscal 2017.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2025-09-30 | $5.42M 10-Q · filed 2025-10-29 | $10.59M derived: sum of 2 quarters · filed 2025-10-29 | $13.50M 10-Q · filed 2025-10-29 | ||||
| 2025-06-30 | $5.17M 10-Q · filed 2025-08-05 | $8.08M 10-Q · filed 2025-08-05 | |||||
| 2025-03-31 | $2.91M 10-Q · filed 2025-05-08 | ||||||
| 2024-09-30 | $5.00M 10-Q · filed 2025-10-29 | $8.91M derived: sum of 2 quarters · filed 2025-10-29 | $12.83M 10-Q · filed 2025-10-29 | ||||
| 2024-06-30 | $3.91M 10-Q · filed 2025-08-05 | $7.83M 10-Q · filed 2025-08-05 | |||||
| 2024-03-31 | $3.92M 10-Q · filed 2025-05-08 | ||||||
| 2023-09-30 | $4.75M 10-Q · filed 2024-11-07 | $10.14M derived: sum of 2 quarters · filed 2024-11-07 | $13.09M 10-Q · filed 2024-11-07 | ||||
| 2023-06-30 | $5.39M 10-Q · filed 2024-08-08 | $8.34M 10-Q · filed 2024-08-08 | |||||
| 2023-03-31 | $2.95M 10-Q · filed 2024-05-02 | ||||||
| 2022-09-30 | $3.85M 10-Q · filed 2023-11-07 | $8.76M derived: sum of 2 quarters · filed 2023-11-07 | $11.44M 10-Q · filed 2023-11-07 | $12.95M derived: sum of 4 quarters · filed 2023-11-07 | |||
| 2022-06-30 | $4.91M 10-Q · filed 2023-08-08 | $7.59M 10-Q · filed 2023-08-08 | $9.10M derived: sum of 3 quarters · filed 2023-08-08 | $12.01M derived: sum of 4 quarters · filed 2023-08-08 | |||
| 2022-03-31 | $2.68M 10-Q · filed 2023-05-09 | $4.19M derived: sum of 2 quarters · filed 2023-05-09 | $7.10M derived: sum of 3 quarters · filed 2023-05-09 | $10.90M derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $4.42M derived: sum of 2 quarters · filed 2022-11-08 | $8.22M derived: sum of 3 quarters · filed 2022-11-08 | $10.92M 10-K · filed 2022-02-25 | |||
| 2021-09-30 | $2.91M 10-Q · filed 2022-11-08 | $6.72M derived: sum of 2 quarters · filed 2022-11-08 | $9.41M 10-Q · filed 2022-11-08 | $12.15M derived: sum of 4 quarters · filed 2022-11-08 | |||
| 2021-06-30 | $3.81M 10-Q · filed 2022-08-05 | $6.50M 10-Q · filed 2022-08-05 | $9.24M derived: sum of 3 quarters · filed 2022-08-05 | $12.19M derived: sum of 4 quarters · filed 2022-08-05 | |||
| 2021-03-31 | $2.69M 10-Q · filed 2022-05-05 | $5.44M derived: sum of 2 quarters · filed 2022-05-05 | $8.39M derived: sum of 3 quarters · filed 2022-05-05 | $10.61M derived: sum of 4 quarters · filed 2022-05-05 | |||
| 2020-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $5.69M derived: sum of 2 quarters · filed 2022-02-25 | $7.91M derived: sum of 3 quarters · filed 2022-02-25 | $8.47M 10-K · filed 2022-02-25 | |||
| 2020-09-30 | $2.95M 10-Q · filed 2021-11-04 | $5.17M derived: sum of 2 quarters · filed 2021-11-04 | $5.72M 10-Q · filed 2021-11-04 | $8.64M derived: sum of 4 quarters · filed 2022-02-25 | |||
| 2020-06-30 | $2.22M 10-Q · filed 2021-08-05 | $2.78M 10-Q · filed 2021-08-05 | $5.70M derived: sum of 3 quarters · filed 2022-02-25 | $8.09M derived: sum of 4 quarters · filed 2022-02-25 | |||
| 2020-03-31 | $556.00K 10-Q · filed 2021-05-06 | $3.48M derived: sum of 2 quarters · filed 2022-02-25 | $5.87M derived: sum of 3 quarters · filed 2022-02-25 | $8.54M derived: sum of 4 quarters · filed 2022-02-25 | |||
| 2019-12-31 | $2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $5.32M derived: sum of 2 quarters · filed 2022-02-25 | $7.99M derived: sum of 3 quarters · filed 2022-02-25 | $10.30M 10-K · filed 2022-02-25 | |||
| 2019-09-30 | $2.40M 10-Q · filed 2020-10-30 | $5.07M derived: sum of 2 quarters · filed 2020-10-30 | $7.38M 10-Q · filed 2020-10-30 | $9.01M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-06-30 | $2.67M 10-Q · filed 2020-08-07 | $4.99M 10-Q · filed 2020-08-07 | $6.61M derived: sum of 3 quarters · filed 2021-03-01 | $8.82M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-03-31 | $2.31M 10-Q · filed 2020-05-06 | $3.94M derived: sum of 2 quarters · filed 2021-03-01 | $6.15M derived: sum of 3 quarters · filed 2021-03-01 | $8.19M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2018-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $3.84M derived: sum of 2 quarters · filed 2021-03-01 | $5.88M derived: sum of 3 quarters · filed 2021-03-01 | $7.61M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $2.21M 10-Q · filed 2019-11-06 | $2.20M 10-Q · filed 2018-10-29 | $4.25M derived: sum of 2 quarters · filed 2019-11-06 | $5.98M 10-Q · filed 2019-11-06 | $6.00M 10-Q · filed 2018-10-29 | $7.09M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2018-06-30 | $2.04M 10-Q · filed 2019-08-06 | $2.00M 10-Q · filed 2018-08-01 | $3.77M 10-Q · filed 2019-08-06 | $4.88M derived: sum of 3 quarters · filed 2020-02-24 | $5.80M derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2018-03-31 | $1.73M 10-Q · filed 2019-05-08 | $2.84M derived: sum of 2 quarters · filed 2020-02-24 | $3.76M derived: sum of 3 quarters · filed 2020-02-24 | $4.48M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2017-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $2.03M derived: sum of 2 quarters · filed 2020-02-24 | $2.75M derived: sum of 3 quarters · filed 2020-02-24 | $3.61M 10-K · filed 2020-02-24 | |||
| 2017-09-30 | $919.00K 10-Q · filed 2018-10-29 | $1.64M derived: sum of 2 quarters · filed 2018-10-29 | $2.50M 10-Q · filed 2018-10-29 | ||||
| 2017-06-30 | $724.00K 10-Q · filed 2018-08-01 | ||||||
| 2015-12-31 | $1.32M 10-K · filed 2016-02-29 | ||||||
| 2014-12-31 | $956.45K 10-K · filed 2016-02-29 | ||||||
| 2013-12-31 | $671.89K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-05 | $671.89K derived: sum of 2 quarters · filed 2015-03-05 | $671.89K derived: sum of 3 quarters · filed 2015-03-05 | $671.89K 10-K · filed 2015-03-05 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $0.00 derived: sum of 2 quarters · filed 2013-10-30 | $0.00 10-Q · filed 2013-10-30 | $495.08K derived: sum of 4 quarters · filed 2014-03-06 | |||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $0.00 10-Q · filed 2013-08-14 | $495.08K derived: sum of 3 quarters · filed 2014-03-06 | $666.09K derived: sum of 4 quarters · filed 2014-03-06 | |||
| 2013-03-31 | $0.00 10-Q · filed 2013-04-30 | $495.08K derived: sum of 2 quarters · filed 2014-03-06 | $666.09K derived: sum of 3 quarters · filed 2014-03-06 | $815.92K derived: sum of 4 quarters · filed 2014-03-06 | |||
| 2012-12-31 | $495.08K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-06 | $666.09K derived: sum of 2 quarters · filed 2014-03-06 | $815.92K derived: sum of 3 quarters · filed 2014-03-06 | $495.08K 10-K · filed 2014-03-06 | |||
| 2012-09-30 | $171.02K 10-Q · filed 2012-11-06 | $320.84K derived: sum of 2 quarters · filed 2012-11-06 | $0.00 10-Q · filed 2013-10-30 | $478.70K 10-Q · filed 2012-11-06 | $238.34K derived: sum of 4 quarters · filed 2013-08-07 | ||
| 2012-06-30 | $149.83K 10-Q · filed 2012-08-14 | $0.00 10-Q · filed 2013-08-14 | $307.69K 10-Q · filed 2012-08-14 | $67.33K derived: sum of 3 quarters · filed 2013-08-07 | $104.83K derived: sum of 4 quarters · filed 2013-08-07 | ||
| 2012-03-31 | $0.00 10-Q · filed 2013-04-30 | -$82.50K derived: sum of 2 quarters · filed 2013-08-07 | -$45.00K derived: sum of 3 quarters · filed 2013-08-07 | -$15.00K derived: sum of 4 quarters · filed 2013-08-07 | |||
| 2011-12-31 | -$82.50K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-08-07 | -$45.00K derived: sum of 2 quarters · filed 2013-08-07 | -$15.00K derived: sum of 3 quarters · filed 2013-08-07 | $15.00K 10-K/A · filed 2013-08-07 | |||
| 2011-09-30 | $37.50K 10-Q · filed 2012-11-06 | $67.50K derived: sum of 2 quarters · filed 2012-11-06 | $97.50K 10-Q · filed 2012-11-06 | ||||
| 2011-06-30 | $30.00K 10-Q · filed 2012-08-14 | $60.00K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |